Data Dialogue with the Oncology Brothers

Rohit Gosain, MD; Rahul Gosain, MD; and Joshua Sabari, MD, discuss how key oncology studies presented at the European Lung Cancer Conference (ELCC 2025)—including KEYNOTE-799, LAURA, and MARIPOSA—demonstrate significant advances in treatment approaches for non–small cell lung cancer, with detailed examination of response rates, survival benefits, safety profiles, and the importance of next-generation sequencing to guide therapeutic decisions.

Panelists discuss critical clinical trial endpoints including overall survival, progression-free survival, event-free survival, overall response rates, and duration of response across neoadjuvant and adjuvant approaches, with particular emphasis on recent data presented at ASCO 2025.

Panelists discuss the key findings and emerging treatments for lymphoma presented at the American Society for Hematology Meeting and Exposition (ASH) 2024, focusing on novel therapies, clinical trial results, and their potential impact on current treatment strategies.

Panelists discuss key highlights from HR-positive (HR+) breast cancer research presented at the 2024 San Antonio Breast Cancer Symposium (SABCS).

Panelists discuss key highlights from SABCS 2024, focusing on the latest research, advancements, and emerging trends in breast cancer treatment and care.

Rahul Gosain, MD, MBA; Rohit Gosain, MD, and John Allan, MD, analyze significant developments in chronic lymphocytic leukemia (CLL) treatment, including 5-year SEQUOIA trial outcomes, AMPLIFY survival data, sonrotoclax-zanubrutinib combination therapy, and the emerging role of CAR T-cell therapy, as presented at the 2024 American Society of Hematology (ASH) Annual Meeting.

With the Oncology Brothers, Uma Borate, MD, discusses ASH 2024 highlights in regard to key studies in leukemia treatment and management.

With Stephen Liu, MD, the Oncology Brothers review 4 major studies highlighted at the European Society for Medical Oncology (ESMO) Congress 2024, including the LAURA study, the MARIPOSA and MARIPOSA-2 studies, and the ADRIATIC study.

Rahul Gosain, MD; Rohit Gosain, MD; and Kristen Ciombor, MD, discuss recent clinical trial results from ESMO 2024, including LEAP-012 in lung cancer, KEYNOTE-811 in gastric cancer, POD1UM-303/InterAACT2 in anal cancer, and NICHE-2 in colorectal cancer, highlighting advancements in immunotherapy and targeted treatments across multiple tumor types.

Rahul Gosain, MD; Rohit Gosain, MD, and Petros Grivas, MD, examine recent oncology studies presented at ESMO 2024, including TiNivo-2, PEACE-3, and CONTACT-02, focusing on survival outcomes, combination therapies, and treatment efficacy in specific patient populations with metastatic disease.

Rahul Gosain, MD; Rohit Gosain, MD, and Paolo Tarantino, MD, analyze recent oncology trial results presented at ESMO 2024, focusing on primary endpoints, survival outcomes, and progression-free survival data across multiple studies including NATALEE, KEYNOTE-522, and DESTINYBreast-12.

Experts at World Conference on Lung Cancer 2024 analyze critical lung cancer studies including HARMONi-02, SKIPPirr, and TROPION-Lung01, examining end points such as progression-free survival, overall survival across histologies, and the potential of novel treatments like amivantamab to advance therapeutic strategies for various patient subgroups.

Following the 2024 ASCO Annual Meeting, Mark A. Lewis, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent updates in gastrointestinal cancer.

Following the 2024 ASCO Annual Meeting, Toni Choueiri, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss recent updates in genitourinary cancer.

Following the 2024 ASCO Annual Meeting, Erika P. Hamilton, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to review recent updates in breast cancer.

Joshua K. Sabari, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss recent updates and exciting data presented at the 2024 ASCO Annual Meeting.

Following ASCO GU 2024, Tian Zhang, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to review recent data in patients with genitourinary cancers.

Following GI ASCO 2024, Pamela Kunz, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in colorectal cancer, hepatocellular carcinoma, neuroendocrine tumor, and the role of ctDNA.

Following ASH 2023, Uma Borate, MBBS, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in myelofibrosis and acute myeloid leukemia.

Following SABCS 2023, Daniel Stover, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in HER2+ Breast Cancer.

Following the 2023 San Antonio Breast Cancer Symposium, Hope Rugo, MD joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in HR+, HER2- Breast Cancer.

Following ASH 2023, Mazyar Shadman, MD, MPH, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss key data updates in leukemia and lymphoma presented at the 2023 ASH Annual Meeting.

Following ASH 2023, Jens Hillengass, MD, PhD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss key data updates in multiple myeloma presented at the 2023 ASH Annual Meeting.

Following SABCS 2023, Eleonora Teplinsky, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in breast cancer.

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Rachna Shroff, MD, to discuss recent data updates in gastrointestinal cancers from clinical trials presented at the 2023 ESMO Congress Meeting.

Join the Oncology Brothers as they work with expert Alexander Spira, MD, PhD, FACP, in reviewing key updates from ESMO 2023 centered on the management of lung cancer.

Following ESMO 2023, Erika P. Hamilton, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent clinical trial data in breast cancer.